https://stock.noler.com/us/stock/optimer-pharmaceuticals-inc https://stock.noler.com/us/stock/optimer-pharmaceuticals-inc/accounts-and-other-receivables-net-current https://stock.noler.com/us/stock/optimer-pharmaceuticals-inc/accounts-payable https://stock.noler.com/us/stock/optimer-pharmaceuticals-inc/accounts-receivable https://stock.noler.com/us/stock/optimer-pharmaceuticals-inc/accrued-income-taxes-noncurrent https://stock.noler.com/us/stock/optimer-pharmaceuticals-inc/accrued-liabilities-current https://stock.noler.com/us/stock/optimer-pharmaceuticals-inc/accrued-professional-fees-current https://stock.noler.com/us/stock/optimer-pharmaceuticals-inc/accrued-royalties-current https://stock.noler.com/us/stock/optimer-pharmaceuticals-inc/accumulated-depreciation https://stock.noler.com/us/stock/optimer-pharmaceuticals-inc/activist-13d-13g-form-sc-13g https://stock.noler.com/us/stock/optimer-pharmaceuticals-inc/additional-paid-in-capital-common-stock https://stock.noler.com/us/stock/optimer-pharmaceuticals-inc/allocated-share-based-compensation-expense https://stock.noler.com/us/stock/optimer-pharmaceuticals-inc/amended-reports-10-k https://stock.noler.com/us/stock/optimer-pharmaceuticals-inc/antidilutive-securities-excluded-from-computation-of-earnings-per-share-amount https://stock.noler.com/us/stock/optimer-pharmaceuticals-inc/aoci https://stock.noler.com/us/stock/optimer-pharmaceuticals-inc/available-for-sale-debt-amortized-cost-basis https://stock.noler.com/us/stock/optimer-pharmaceuticals-inc/available-for-sale-debt-maturities-next-rolling-twelve-months-amortized-cost-basis https://stock.noler.com/us/stock/optimer-pharmaceuticals-inc/available-for-sale-debt-maturities-next-rolling-twelve-months-fair-value https://stock.noler.com/us/stock/optimer-pharmaceuticals-inc/available-for-sale-debt-maturities-within-one-year-amortized-cost https://stock.noler.com/us/stock/optimer-pharmaceuticals-inc/available-for-sale-debt-maturities-within-one-year-fair-value https://stock.noler.com/us/stock/optimer-pharmaceuticals-inc/available-for-sale-debt-securities https://stock.noler.com/us/stock/optimer-pharmaceuticals-inc/available-for-sale-gross-realized-gain-loss-net https://stock.noler.com/us/stock/optimer-pharmaceuticals-inc/available-for-sale-gross-unrealized-gain https://stock.noler.com/us/stock/optimer-pharmaceuticals-inc/available-for-sale-gross-unrealized-losses https://stock.noler.com/us/stock/optimer-pharmaceuticals-inc/basic-shares https://stock.noler.com/us/stock/optimer-pharmaceuticals-inc/capital-expenditures https://stock.noler.com/us/stock/optimer-pharmaceuticals-inc/cash-and-equivalents https://stock.noler.com/us/stock/optimer-pharmaceuticals-inc/cash-cash-equivalents-and-short-term-investments https://stock.noler.com/us/stock/optimer-pharmaceuticals-inc/cash-divested-from-deconsolidation https://stock.noler.com/us/stock/optimer-pharmaceuticals-inc/cash-flow-breakdown https://stock.noler.com/us/stock/optimer-pharmaceuticals-inc/class-of-warrant-or-right-exercise-price-of-warrants-or-rights https://stock.noler.com/us/stock/optimer-pharmaceuticals-inc/class-of-warrant-or-right-number-of-securities-called-by-warrants-or-rights https://stock.noler.com/us/stock/optimer-pharmaceuticals-inc/common-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/optimer-pharmaceuticals-inc/common-stock-value https://stock.noler.com/us/stock/optimer-pharmaceuticals-inc/comprehensive-income https://stock.noler.com/us/stock/optimer-pharmaceuticals-inc/comprehensive-income-net-of-tax-including-portion-attributable-to-noncontrolling-interest https://stock.noler.com/us/stock/optimer-pharmaceuticals-inc/cost-of-goods-sold https://stock.noler.com/us/stock/optimer-pharmaceuticals-inc/costs-and-expenses https://stock.noler.com/us/stock/optimer-pharmaceuticals-inc/cover-page-shares-outstanding https://stock.noler.com/us/stock/optimer-pharmaceuticals-inc/current-assets https://stock.noler.com/us/stock/optimer-pharmaceuticals-inc/current-federal-tax-expense-benefit https://stock.noler.com/us/stock/optimer-pharmaceuticals-inc/current-income-tax-expense-benefit https://stock.noler.com/us/stock/optimer-pharmaceuticals-inc/current-liabilities https://stock.noler.com/us/stock/optimer-pharmaceuticals-inc/current-state-and-local-tax-expense-benefit https://stock.noler.com/us/stock/optimer-pharmaceuticals-inc/deconsolidation-gain-or-loss-amount https://stock.noler.com/us/stock/optimer-pharmaceuticals-inc/deferred-federal-income-tax-expense-benefit https://stock.noler.com/us/stock/optimer-pharmaceuticals-inc/deferred-income-tax-expense-benefit https://stock.noler.com/us/stock/optimer-pharmaceuticals-inc/deferred-rent-credit-noncurrent https://stock.noler.com/us/stock/optimer-pharmaceuticals-inc/deferred-revenue https://stock.noler.com/us/stock/optimer-pharmaceuticals-inc/deferred-state-and-local-income-tax-expense-benefit https://stock.noler.com/us/stock/optimer-pharmaceuticals-inc/deferred-tax-assets-goodwill-and-intangible-assets https://stock.noler.com/us/stock/optimer-pharmaceuticals-inc/deferred-tax-assets-gross https://stock.noler.com/us/stock/optimer-pharmaceuticals-inc/deferred-tax-assets-liabilities-net-noncurrent https://stock.noler.com/us/stock/optimer-pharmaceuticals-inc/deferred-tax-assets-net https://stock.noler.com/us/stock/optimer-pharmaceuticals-inc/deferred-tax-assets-operating-loss-carryforwards https://stock.noler.com/us/stock/optimer-pharmaceuticals-inc/deferred-tax-assets-other https://stock.noler.com/us/stock/optimer-pharmaceuticals-inc/deferred-tax-assets-stock-compensation https://stock.noler.com/us/stock/optimer-pharmaceuticals-inc/deferred-tax-assets-tax-credit-carryforwards https://stock.noler.com/us/stock/optimer-pharmaceuticals-inc/deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/optimer-pharmaceuticals-inc/deferred-tax-liabilities-investments https://stock.noler.com/us/stock/optimer-pharmaceuticals-inc/defined-contribution-plan-employer-matching-contribution-percent https://stock.noler.com/us/stock/optimer-pharmaceuticals-inc/defined-contribution-plan-maximum-annual-contribution-per-employee-percent https://stock.noler.com/us/stock/optimer-pharmaceuticals-inc/depreciation-and-amortization https://stock.noler.com/us/stock/optimer-pharmaceuticals-inc/diluted-shares https://stock.noler.com/us/stock/optimer-pharmaceuticals-inc/earnings-per-share-basic-and-diluted https://stock.noler.com/us/stock/optimer-pharmaceuticals-inc/effect-of-exchange-rate-on-cash-and-cash-equivalents https://stock.noler.com/us/stock/optimer-pharmaceuticals-inc/employee-related-liabilities-current https://stock.noler.com/us/stock/optimer-pharmaceuticals-inc/eps https://stock.noler.com/us/stock/optimer-pharmaceuticals-inc/eps-basic https://stock.noler.com/us/stock/optimer-pharmaceuticals-inc/equity-method-investment-ownership-percentage https://stock.noler.com/us/stock/optimer-pharmaceuticals-inc/equity-method-investments https://stock.noler.com/us/stock/optimer-pharmaceuticals-inc/exchange-rate-effect-on-cash https://stock.noler.com/us/stock/optimer-pharmaceuticals-inc/financing-cash-flow https://stock.noler.com/us/stock/optimer-pharmaceuticals-inc/foreign-pretax-income https://stock.noler.com/us/stock/optimer-pharmaceuticals-inc/gain-loss-on-disposition-of-assets https://stock.noler.com/us/stock/optimer-pharmaceuticals-inc/gain-or-loss-on-sale-of-stock-in-subsidiary https://stock.noler.com/us/stock/optimer-pharmaceuticals-inc/general-and-administrative-expense https://stock.noler.com/us/stock/optimer-pharmaceuticals-inc/grants-receivable https://stock.noler.com/us/stock/optimer-pharmaceuticals-inc/income-loss-from-equity-method-investments https://stock.noler.com/us/stock/optimer-pharmaceuticals-inc/income-tax https://stock.noler.com/us/stock/optimer-pharmaceuticals-inc/income-tax-at-federal-statutory-rate https://stock.noler.com/us/stock/optimer-pharmaceuticals-inc/increase-decrease-in-accounts-and-other-receivables https://stock.noler.com/us/stock/optimer-pharmaceuticals-inc/increase-decrease-in-accounts-payable-and-accrued-liabilities https://stock.noler.com/us/stock/optimer-pharmaceuticals-inc/increase-decrease-in-accounts-receivable https://stock.noler.com/us/stock/optimer-pharmaceuticals-inc/increase-decrease-in-accrued-income-taxes-payable https://stock.noler.com/us/stock/optimer-pharmaceuticals-inc/increase-decrease-in-deferred-revenue https://stock.noler.com/us/stock/optimer-pharmaceuticals-inc/increase-decrease-in-inventories https://stock.noler.com/us/stock/optimer-pharmaceuticals-inc/increase-decrease-in-other-operating-assets https://stock.noler.com/us/stock/optimer-pharmaceuticals-inc/increase-decrease-in-other-receivables https://stock.noler.com/us/stock/optimer-pharmaceuticals-inc/increase-decrease-in-prepaid-deferred-expense-and-other-assets https://stock.noler.com/us/stock/optimer-pharmaceuticals-inc/insider-transactions-other https://stock.noler.com/us/stock/optimer-pharmaceuticals-inc/insider-transactions-preferred https://stock.noler.com/us/stock/optimer-pharmaceuticals-inc/insider-transactions-stock-options https://stock.noler.com/us/stock/optimer-pharmaceuticals-inc/insider-transactions-warrants https://stock.noler.com/us/stock/optimer-pharmaceuticals-inc/insider-transactions-warrants/purchases https://stock.noler.com/us/stock/optimer-pharmaceuticals-inc/inventory https://stock.noler.com/us/stock/optimer-pharmaceuticals-inc/inventory-adjustments https://stock.noler.com/us/stock/optimer-pharmaceuticals-inc/inventory-finished-goods https://stock.noler.com/us/stock/optimer-pharmaceuticals-inc/inventory-gross https://stock.noler.com/us/stock/optimer-pharmaceuticals-inc/inventory-raw-materials https://stock.noler.com/us/stock/optimer-pharmaceuticals-inc/inventory-valuation-reserves https://stock.noler.com/us/stock/optimer-pharmaceuticals-inc/inventory-work-in-process https://stock.noler.com/us/stock/optimer-pharmaceuticals-inc/investing-cash-flow https://stock.noler.com/us/stock/optimer-pharmaceuticals-inc/issuance-of-stock-and-warrants-for-services-or-claims https://stock.noler.com/us/stock/optimer-pharmaceuticals-inc/late-filing-notices-nt-10-k https://stock.noler.com/us/stock/optimer-pharmaceuticals-inc/license-costs https://stock.noler.com/us/stock/optimer-pharmaceuticals-inc/licenses-revenue https://stock.noler.com/us/stock/optimer-pharmaceuticals-inc/long-term-investments https://stock.noler.com/us/stock/optimer-pharmaceuticals-inc/marketing-and-advertising-expense https://stock.noler.com/us/stock/optimer-pharmaceuticals-inc/marketing-expense https://stock.noler.com/us/stock/optimer-pharmaceuticals-inc/minority-interest https://stock.noler.com/us/stock/optimer-pharmaceuticals-inc/minority-interest-increase-from-stock-issuance https://stock.noler.com/us/stock/optimer-pharmaceuticals-inc/net-cash-from https://stock.noler.com/us/stock/optimer-pharmaceuticals-inc/net-cash-from-financing-activities https://stock.noler.com/us/stock/optimer-pharmaceuticals-inc/net-cash-from-investing-activities https://stock.noler.com/us/stock/optimer-pharmaceuticals-inc/net-cash-from-operating-activities https://stock.noler.com/us/stock/optimer-pharmaceuticals-inc/net-change-in-cash https://stock.noler.com/us/stock/optimer-pharmaceuticals-inc/net-income https://stock.noler.com/us/stock/optimer-pharmaceuticals-inc/net-income-loss-attributable-to-noncontrolling-interest https://stock.noler.com/us/stock/optimer-pharmaceuticals-inc/net-income-loss-available-to-common-stockholders-basic https://stock.noler.com/us/stock/optimer-pharmaceuticals-inc/noncash-or-part-noncash-acquisition-fixed-assets-acquired https://stock.noler.com/us/stock/optimer-pharmaceuticals-inc/noncontrolling-interest-decrease-from-deconsolidation https://stock.noler.com/us/stock/optimer-pharmaceuticals-inc/number-of-operating-segments https://stock.noler.com/us/stock/optimer-pharmaceuticals-inc/oci-available-for-sale-adjustment-net-of-tax https://stock.noler.com/us/stock/optimer-pharmaceuticals-inc/oci-foreign-currency-transaction-and-translation-adjustment-net-of-tax https://stock.noler.com/us/stock/optimer-pharmaceuticals-inc/oci-foreign-currency-transaction-and-translation-adjustment-net-of-tax-2 https://stock.noler.com/us/stock/optimer-pharmaceuticals-inc/oci-foreign-currency-transaction-and-translation-adjustment-net-of-tax-change https://stock.noler.com/us/stock/optimer-pharmaceuticals-inc/oci-net-of-tax https://stock.noler.com/us/stock/optimer-pharmaceuticals-inc/oci-securities-sale-reclassification-net-of-tax https://stock.noler.com/us/stock/optimer-pharmaceuticals-inc/oci-tax https://stock.noler.com/us/stock/optimer-pharmaceuticals-inc/oci-unrealized-holding-gain-loss-on-securities-arising-net-of-tax https://stock.noler.com/us/stock/optimer-pharmaceuticals-inc/operating-cash-flow https://stock.noler.com/us/stock/optimer-pharmaceuticals-inc/operating-income https://stock.noler.com/us/stock/optimer-pharmaceuticals-inc/operating-lease-payments-due https://stock.noler.com/us/stock/optimer-pharmaceuticals-inc/operating-lease-payments-due-current https://stock.noler.com/us/stock/optimer-pharmaceuticals-inc/operating-lease-payments-due-in-four-years https://stock.noler.com/us/stock/optimer-pharmaceuticals-inc/operating-lease-payments-due-in-three-years https://stock.noler.com/us/stock/optimer-pharmaceuticals-inc/operating-lease-payments-due-in-two-years https://stock.noler.com/us/stock/optimer-pharmaceuticals-inc/operating-leases-rent-expense-net https://stock.noler.com/us/stock/optimer-pharmaceuticals-inc/other-accrued-liabilities-current https://stock.noler.com/us/stock/optimer-pharmaceuticals-inc/other-income https://stock.noler.com/us/stock/optimer-pharmaceuticals-inc/other-noncash-income-tax-expense https://stock.noler.com/us/stock/optimer-pharmaceuticals-inc/other-noncurrent-assets https://stock.noler.com/us/stock/optimer-pharmaceuticals-inc/other-receivables https://stock.noler.com/us/stock/optimer-pharmaceuticals-inc/other-sales-revenue-net https://stock.noler.com/us/stock/optimer-pharmaceuticals-inc/other-than-temporary-impairment-losses-investments-portion-recognized-in-earnings-net-available-for-sale-securities https://stock.noler.com/us/stock/optimer-pharmaceuticals-inc/paid-in-capital-stock-compensation https://stock.noler.com/us/stock/optimer-pharmaceuticals-inc/payments-to-acquire-equity-method-investments https://stock.noler.com/us/stock/optimer-pharmaceuticals-inc/payments-to-acquire-short-term-investments https://stock.noler.com/us/stock/optimer-pharmaceuticals-inc/preferred-shares-facts https://stock.noler.com/us/stock/optimer-pharmaceuticals-inc/preferred-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/optimer-pharmaceuticals-inc/preferred-stock-shares-authorized https://stock.noler.com/us/stock/optimer-pharmaceuticals-inc/preferred-stock-shares-issued https://stock.noler.com/us/stock/optimer-pharmaceuticals-inc/preferred-stock-shares-outstanding https://stock.noler.com/us/stock/optimer-pharmaceuticals-inc/prepaid-expense-and-other-assets-current https://stock.noler.com/us/stock/optimer-pharmaceuticals-inc/pretax-income-domestic https://stock.noler.com/us/stock/optimer-pharmaceuticals-inc/pretax-income-minority-interest-and-income-loss-from-equity-method-investments https://stock.noler.com/us/stock/optimer-pharmaceuticals-inc/proceeds-from-other-equity https://stock.noler.com/us/stock/optimer-pharmaceuticals-inc/proceeds-from-sale-of-available-for-sale-equity https://stock.noler.com/us/stock/optimer-pharmaceuticals-inc/proceeds-from-sale-of-equity-method-investments https://stock.noler.com/us/stock/optimer-pharmaceuticals-inc/proceeds-from-sale-of-productive-assets https://stock.noler.com/us/stock/optimer-pharmaceuticals-inc/proceeds-from-sale-of-short-term-investments https://stock.noler.com/us/stock/optimer-pharmaceuticals-inc/proceeds-from-stock-issued https://stock.noler.com/us/stock/optimer-pharmaceuticals-inc/profit-loss https://stock.noler.com/us/stock/optimer-pharmaceuticals-inc/property-plant-and-equipment-gross https://stock.noler.com/us/stock/optimer-pharmaceuticals-inc/property-plant-equipment https://stock.noler.com/us/stock/optimer-pharmaceuticals-inc/public-float https://stock.noler.com/us/stock/optimer-pharmaceuticals-inc/purchase-obligations-balance-sheet-amount https://stock.noler.com/us/stock/optimer-pharmaceuticals-inc/research-and-development https://stock.noler.com/us/stock/optimer-pharmaceuticals-inc/retained-earnings https://stock.noler.com/us/stock/optimer-pharmaceuticals-inc/revenue https://stock.noler.com/us/stock/optimer-pharmaceuticals-inc/revenue-from-grants https://stock.noler.com/us/stock/optimer-pharmaceuticals-inc/sales-allowances-price-protection https://stock.noler.com/us/stock/optimer-pharmaceuticals-inc/sales-discounts-goods https://stock.noler.com/us/stock/optimer-pharmaceuticals-inc/sales-discounts-returns-and-allowances-goods https://stock.noler.com/us/stock/optimer-pharmaceuticals-inc/sales-returns-goods https://stock.noler.com/us/stock/optimer-pharmaceuticals-inc/sales-revenue-goods-gross https://stock.noler.com/us/stock/optimer-pharmaceuticals-inc/sales-revenue-goods-net https://stock.noler.com/us/stock/optimer-pharmaceuticals-inc/sec-comment-letters-corresp https://stock.noler.com/us/stock/optimer-pharmaceuticals-inc/sec-comment-letters-upload https://stock.noler.com/us/stock/optimer-pharmaceuticals-inc/sec-filings-10-k https://stock.noler.com/us/stock/optimer-pharmaceuticals-inc/sec-filings-10-q https://stock.noler.com/us/stock/optimer-pharmaceuticals-inc/sec-filings-15-12b https://stock.noler.com/us/stock/optimer-pharmaceuticals-inc/sec-filings-25-nse https://stock.noler.com/us/stock/optimer-pharmaceuticals-inc/sec-filings-425 https://stock.noler.com/us/stock/optimer-pharmaceuticals-inc/sec-filings-8-a12b https://stock.noler.com/us/stock/optimer-pharmaceuticals-inc/sec-filings-8-k https://stock.noler.com/us/stock/optimer-pharmaceuticals-inc/sec-filings-ars https://stock.noler.com/us/stock/optimer-pharmaceuticals-inc/sec-filings-certnas https://stock.noler.com/us/stock/optimer-pharmaceuticals-inc/sec-filings-ct-order https://stock.noler.com/us/stock/optimer-pharmaceuticals-inc/sec-filings-def-14a https://stock.noler.com/us/stock/optimer-pharmaceuticals-inc/sec-filings-defa14a https://stock.noler.com/us/stock/optimer-pharmaceuticals-inc/sec-filings-defm14a https://stock.noler.com/us/stock/optimer-pharmaceuticals-inc/sec-filings-pre-14a https://stock.noler.com/us/stock/optimer-pharmaceuticals-inc/sec-filings-regdex https://stock.noler.com/us/stock/optimer-pharmaceuticals-inc/secondary-offerings-form-424b2 https://stock.noler.com/us/stock/optimer-pharmaceuticals-inc/secondary-offerings-form-424b3 https://stock.noler.com/us/stock/optimer-pharmaceuticals-inc/secondary-offerings-form-424b4 https://stock.noler.com/us/stock/optimer-pharmaceuticals-inc/secondary-offerings-form-424b5 https://stock.noler.com/us/stock/optimer-pharmaceuticals-inc/secondary-offerings-form-effect https://stock.noler.com/us/stock/optimer-pharmaceuticals-inc/secondary-offerings-form-fwp https://stock.noler.com/us/stock/optimer-pharmaceuticals-inc/secondary-offerings-form-pos-am https://stock.noler.com/us/stock/optimer-pharmaceuticals-inc/secondary-offerings-form-s-1 https://stock.noler.com/us/stock/optimer-pharmaceuticals-inc/secondary-offerings-form-s-3 https://stock.noler.com/us/stock/optimer-pharmaceuticals-inc/secondary-offerings-form-s-8 https://stock.noler.com/us/stock/optimer-pharmaceuticals-inc/secondary-offerings-form-s-8-pos https://stock.noler.com/us/stock/optimer-pharmaceuticals-inc/segment-reporting-information-revenue https://stock.noler.com/us/stock/optimer-pharmaceuticals-inc/sga-expense https://stock.noler.com/us/stock/optimer-pharmaceuticals-inc/shareholders-equity https://stock.noler.com/us/stock/optimer-pharmaceuticals-inc/shares-authorized https://stock.noler.com/us/stock/optimer-pharmaceuticals-inc/shares-issued https://stock.noler.com/us/stock/optimer-pharmaceuticals-inc/shares-issued-shares-issued-for-services https://stock.noler.com/us/stock/optimer-pharmaceuticals-inc/shares-issued-shares-new-issues https://stock.noler.com/us/stock/optimer-pharmaceuticals-inc/shares-issued-shares-other https://stock.noler.com/us/stock/optimer-pharmaceuticals-inc/short-term-investments https://stock.noler.com/us/stock/optimer-pharmaceuticals-inc/stock-based-compensation https://stock.noler.com/us/stock/optimer-pharmaceuticals-inc/stock-compensation-unrecognized-cost https://stock.noler.com/us/stock/optimer-pharmaceuticals-inc/stock-issued-new-shares-sold https://stock.noler.com/us/stock/optimer-pharmaceuticals-inc/stock-issued-shares-issued-value-espp https://stock.noler.com/us/stock/optimer-pharmaceuticals-inc/stock-issued-shares-issued-value-issued-for-services https://stock.noler.com/us/stock/optimer-pharmaceuticals-inc/stock-issued-shares-issued-value-other https://stock.noler.com/us/stock/optimer-pharmaceuticals-inc/stock-issued-shares-issued-value-share-based-compensation-gross https://stock.noler.com/us/stock/optimer-pharmaceuticals-inc/stock-issued-shares-issued-value-stock-options-exercised https://stock.noler.com/us/stock/optimer-pharmaceuticals-inc/stockholders-equity-including-portion-attributable-to-noncontrolling-interest https://stock.noler.com/us/stock/optimer-pharmaceuticals-inc/tax-reconciliation-change-in-deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/optimer-pharmaceuticals-inc/tax-reconciliation-change-in-enacted-tax-rate https://stock.noler.com/us/stock/optimer-pharmaceuticals-inc/tax-reconciliation-disposition-of-business https://stock.noler.com/us/stock/optimer-pharmaceuticals-inc/tax-reconciliation-foreign-income-tax-rate-differential https://stock.noler.com/us/stock/optimer-pharmaceuticals-inc/tax-reconciliation-nondeductible-expense https://stock.noler.com/us/stock/optimer-pharmaceuticals-inc/tax-reconciliation-nondeductible-expense-meals-and-entertainment https://stock.noler.com/us/stock/optimer-pharmaceuticals-inc/tax-reconciliation-nondeductible-expense-research-and-development https://stock.noler.com/us/stock/optimer-pharmaceuticals-inc/tax-reconciliation-nondeductible-expense-share-based-compensation-cost https://stock.noler.com/us/stock/optimer-pharmaceuticals-inc/tax-reconciliation-other-adjustments https://stock.noler.com/us/stock/optimer-pharmaceuticals-inc/tax-reconciliation-state-and-local-income-taxes https://stock.noler.com/us/stock/optimer-pharmaceuticals-inc/tax-reconciliation-tax-credits-research https://stock.noler.com/us/stock/optimer-pharmaceuticals-inc/total-assets https://stock.noler.com/us/stock/optimer-pharmaceuticals-inc/total-liabilities-and-equity https://stock.noler.com/us/stock/optimer-pharmaceuticals-inc/unrecognized-tax-benefits https://stock.noler.com/us/stock/optimer-pharmaceuticals-inc/utb-that-would-impact-effective-tax-rate https://stock.noler.com/us/stock/optimer-pharmaceuticals-inc/weighted-average-number-of-share-outstanding-basic-and-diluted https://stock.noler.com/us/stock/optimer-pharmaceuticals-inc/workers-compensation-liability-current